About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results 02-05-2026 at 4:05 PM EST Adaptive Biotechnologies to Participate in Upcoming Investor Conferences 01-27-2026 at 4:05 PM EST Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026 01-22-2026 at 4:05 PM EST VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations TD Cowen 46th Annual Healthcare Conference Mar 2, 2026 at 11:50 AM EST Listen to webcast Adaptive Biotechnologies Fourth Quarter Financial Results Feb 5, 2026 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Q4 and FY 2025 Earnings Presentation 856.2 KB 44th Annual J.P. Morgan Healthcare Conference Jan 12, 2026 at 7:30 PM EST Listen to webcast View Presentation 2.6 MB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Apr 1, 2026 7:42 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
